| __timestamp | Ascendis Pharma A/S | CRISPR Therapeutics AG |
|---|---|---|
| Wednesday, January 1, 2014 | 19698000 | 1513000 |
| Thursday, January 1, 2015 | 40528000 | 12573000 |
| Friday, January 1, 2016 | 66022000 | 42238000 |
| Sunday, January 1, 2017 | 99589000 | 69800000 |
| Monday, January 1, 2018 | 140281000 | 113773000 |
| Tuesday, January 1, 2019 | 191621000 | 179362000 |
| Wednesday, January 1, 2020 | 260904000 | 266946000 |
| Friday, January 1, 2021 | 295867000 | 438633000 |
| Saturday, January 1, 2022 | 379624000 | 461645000 |
| Sunday, January 1, 2023 | 413454000 | 387332000 |
| Monday, January 1, 2024 | 307004000 | 320653000 |
In pursuit of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Ascendis Pharma A/S and CRISPR Therapeutics AG, two leading players in the field, have demonstrated a strategic focus on R&D over the past decade. Since 2014, Ascendis Pharma has increased its R&D expenses by over 2,000%, reaching a peak in 2023. Meanwhile, CRISPR Therapeutics AG has shown a similar upward trajectory, with a remarkable 25% increase in R&D spending from 2020 to 2021 alone. This trend underscores the companies' dedication to advancing cutting-edge therapies and maintaining a competitive edge. As the biotech landscape evolves, these investments are likely to play a pivotal role in shaping the future of healthcare.
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs CRISPR Therapeutics AG
R&D Insights: How Neurocrine Biosciences, Inc. and CRISPR Therapeutics AG Allocate Funds
Ascendis Pharma A/S vs Verona Pharma plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Novavax, Inc.
Research and Development Investment: Ascendis Pharma A/S vs BioCryst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Opthea Limited and CRISPR Therapeutics AG
Analyzing R&D Budgets: Verona Pharma plc vs CRISPR Therapeutics AG
Research and Development Investment: Ultragenyx Pharmaceutical Inc. vs CRISPR Therapeutics AG
Viking Therapeutics, Inc. or CRISPR Therapeutics AG: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for CRISPR Therapeutics AG and Bausch Health Companies Inc.
Analyzing R&D Budgets: CRISPR Therapeutics AG vs Geron Corporation